文献速递认知障碍与痴呆

阿尔茨海默病中小胶质细胞和星形胶质细胞对含tau寡聚体突触的清除

Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.
PubMed 文献 · JAMA Neurol · 2023-01-01

这项横断面尸检研究纳入40例大脑,比较Braak III-IV期伴痴呆与认知弹性者及正常对照,发现痴呆组视觉皮质突触前、后及成熟突触成分显著丢失,小胶质细胞和星形胶质细胞吞噬含tau寡聚体突触的比例显著增高,且发生于无tau缠结沉积区域。

要点

  • 痴呆组较对照突触前成分丢失43%、突触后成分丢失33%、共定位成熟突触成分丢失38%。
  • 痴呆组成熟突触被IBA1阳性小胶质细胞吞噬比例13.3%,弹性组2.6%,对照组0.9%(P < .001)。
  • 痴呆组含tau寡聚体突触被小胶质细胞和星形胶质细胞吞噬比例显著高于对照,且视觉皮质无tau缠结沉积。

核心结论

  • 横断面研究提示,痴呆个体大脑中小胶质细胞和星形胶质细胞可能过度吞噬突触,突触内tau寡聚体异常存在可能作为胶质细胞介导突触清除增加和AD早期脑功能丧失的信号。

研究设计与样本

  • 横断面尸检研究纳入40例人脑,来自马萨诸塞阿尔茨海默病研究中心脑库,包括Braak III至IV期tau病理伴痴呆19例、认知弹性13例及认知正常对照8例(Braak 0-II期),按年龄、性别和载脂蛋白E状态匹配,排除路易体、TDP-43聚集等非AD病变。
  • 组织收集时间为1998年7月至2020年11月,分析时间为2022年2月1日至2023年5月31日。
  • 采用膨胀显微镜评估视觉皮质突触与小胶质细胞和星形胶质细胞的空间关系。

主要发现

  • 与对照相比,痴呆组而非弹性组突触前成分丢失43%、突触后成分丢失33%、共定位成熟突触成分丢失38%。
  • 成熟突触被IBA1阳性小胶质细胞吞噬比例:痴呆组平均13.3%(SD 3.9%) vs 弹性组2.6%(SD 1.9%) vs 对照组0.9%(SD 0.5%),P < .001。
  • 成熟突触被GFAP阳性星形胶质细胞吞噬比例:痴呆组平均17.2%(SD 10.9%) vs 弹性组3.7%(SD 4.0%) vs 对照组2.7%(SD 1.8%),P = .001。
  • 含tau寡聚体突触被小胶质细胞吞噬比例(突触前):痴呆组平均7.4%(SD 1.8%) vs 弹性组5.1%(SD 1.9%) vs 对照组3.7%(SD 0.8%),P = .006;突触后:痴呆组11.6%(SD 3.6%) vs 弹性组6.8%(SD 1.3%) vs 对照组7.4%(SD 2.5%),P = .001。
  • 含tau寡聚体突触被星形胶质细胞吞噬比例(突触前):痴呆组平均7.0%(SD 2.1%) vs 弹性组4.3%(SD 2.2%) vs 对照组4.0%(SD 0.7%),P = .001;突触后:痴呆组7.9%(SD 2.2%) vs 弹性组5.3%(SD 1.8%) vs 对照组3.0%(SD 1.5%),P < .001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Factors associated with synapse loss beyond amyloid-β plaques and neurofibrillary tangles may more closely correlate with the emergence of cognitive deficits in Alzheimer disease (AD) and be relevant for early therapeutic intervention. OBJECTIVE: To investigate whether accumulation of tau oligomers in synapses is associated with excessive synapse elimination by microglia or astrocytes and with cognitive outcomes (dementia vs no dementia [hereinafter termed resilient]) of individuals with equal burdens of AD neuropathologic changes at autopsy. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional postmortem study included 40 human brains from the Massachusetts Alzheimer Disease Research Center Brain Bank with Braak III to IV stages of tau pathology but divergent antemortem cognition (dementia vs resilient) and cognitively normal controls with negligible AD neuropathologic changes. The visual cortex, a region without tau tangle deposition at Braak III to IV stages, was assessed after expansion microscopy to analyze spatial relationships of synapses with microglia and astrocytes. Participants were matched for age, sex, and apolipoprotein E status. Evidence of Lewy bodies, TDP-43 aggregates, or other lesions different from AD neuropathology were exclusion criteria. Tissue was collected from July 1998 to November 2020, and analyses were conducted from February 1, 2022, through May 31, 2023. MAIN OUTCOMES AND MEASURES: Amyloid-β plaques, tau neuropil thread burden, synapse density, tau oligomers in synapses, and internalization of tau oligomer-tagged synapses by microglia and astrocytes were quantitated. Analyses were performed using 1-way analysis of variance for parametric variables and the Kruskal-Wallis test for nonparametric variables; between-group differences were evaluated with Holm-Šídák tests. RESULTS: Of 40 included participants (mean [SD] age at death, 88 [8] years; 21 [52%] male), 19 had early-stage dementia with Braak stages III to IV, 13 had resilient brains with similar Braak stages III to IV, and 8 had no dementia (Braak stages 0-II). Brains with dementia but not resilient brains had substantial loss of presynaptic (43%), postsynaptic (33%), and colocalized mature synaptic elements (38%) compared with controls and significantly higher percentages of mature synapses internalized by IBA1-positive microglia (mean [SD], 13.3% [3.9%] in dementia vs 2.6% [1.9%] in resilient vs 0.9% [0.5%] in control; P < .001) and by GFAP-positive astrocytes (mean [SD], 17.2% [10.9%] in dementia vs 3.7% [4.0%] in resilient vs 2.7% [1.8%] in control; P = .001). In brains with dementia but not in resilient brains, tau oligomers more often colocalized with synapses, and the proportions of tau oligomer-containing synapses inside microglia (mean [SD] for presynapses, mean [SD], 7.4% [1.8%] in dementia vs 5.1% [1.9%] resilient vs 3.7% [0.8%] control; P = .006; and for postsynapses 11.6% [3.6%] dementia vs 6.8% [1.3%] resilient vs 7.4% [2.5%] control; P = .001) and astrocytes (mean [SD] for presynapses, 7.0% [2.1%] dementia vs 4.3% [2.2%] resilient vs 4.0% [0.7%] control; P = .001; and for postsynapses, 7.9% [2.2%] dementia vs 5.3% [1.8%] resilient vs 3.0% [1.5%] control; P < .001) were significantly increased compared with controls. Those changes in brains with dementia occurred in the absence of tau tangle deposition in visual cortex. CONCLUSION AND RELEVANCE: The findings from this cross-sectional study suggest that microglia and astrocytes may excessively engulf synapses in brains of individuals with dementia and that the abnormal presence of tau oligomers in synapses may serve as signals for increased glial-mediated synapse elimination and early loss of brain function in AD.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Taddei RN, Perbet R, Mate de Gerando A, et al. Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease. JAMA Neurol. 2023. PMID: 37812432. doi:10.1001/jamaneurol.2023.3530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。